Neuland is manufacturer of Active Pharmaceutical Ingredients and provider of Contract Research Services. We have been Preferred Source world wide for APIs and Intermediates for over 25 years. We have 2 manufacturing plants which have been thrice each successfully inspected by USFDA. Our facilities have also been successfully inspected by German Health Authority and EDQM. We have a R&D Centre which houses 130 scientists engaged in NCE custom synthesis work. The custom synthesis is complemented by 2 cGMP Kilo Labs, 1 non-GMP Kilo Lab and cGMP Pilot Plant.We offer custom synthesis and manufacturing services to the Pharmaceutical industry. Neuland latest foray is in Generic peptide synthesis and we are currently offering Building Blocks to the market.
Neuland, a $70 Million company, having the largest market share of Ciprofloxacin Hcl in US & Europe has close to 35 products across 10 different therapeutic segments in its portfolio. Neuland is also a proud recipient of ISO 9001 for Quality, ISO 14001 and ISO 18001 for EHS initiatives and ISO 27001 for Information Security.
